PERCEPTIVE ADVISORS LLC

Insider Buys Quantity –
110
2024-04-05PurchaseAldeyra Therapeutics, Inc.
ALDX
10 percent owner
37,712
0.0643%
$4.74$178,755-16.53%
2024-04-04PurchaseAldeyra Therapeutics, Inc.
ALDX
10 percent owner
140,281
0.2374%
$4.67$655,112-15.81%
2024-04-03PurchaseAldeyra Therapeutics, Inc.
ALDX
10 percent owner
309,847
0.5185%
$4.09$1.27M-5.06%
2024-04-02PurchaseAldeyra Therapeutics, Inc.
ALDX
10 percent owner
186,051
0.3061%
$3.44$640,015+10.99%
2024-04-01PurchaseAldeyra Therapeutics, Inc.
ALDX
10 percent owner
8,374
0.0141%
$3.25$27,216+20.49%
2024-02-01PurchaseAstria Therapeutics, Inc.
ATXS
director
2.48M
5.6893%
$12.09$30M-19.69%
2024-01-11PurchaseSolid Biosciences Inc.
SLDB
3.41M
12.2033%
$5.53$18.86M+16.56%
2023-12-29PurchaseAthira Pharma, Inc.
ATHA
163,954
0.4272%
$2.38$390,211+7.5%
2023-12-29PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
115,774
0.2752%
$7.24$838,204-10.9%
2023-12-28PurchaseAthira Pharma, Inc.
ATHA
409,598
1.0852%
$2.44$999,419+5.1%
2023-12-28PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
126,116
0.2934%
$7.08$892,901-10.48%
2023-12-27PurchaseAthira Pharma, Inc.
ATHA
32,134
0.0833%
$2.28$73,266+11.74%
2023-12-27PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
79,726
0.1901%
$7.20$574,027-7.51%
2023-12-26PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
54,652
0.1301%
$6.49$354,691+2.77%
2023-12-22PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
250,000
0.5943%
$6.67$1.67M-1.48%
2023-12-21PurchaseAstria Therapeutics, Inc.
ATXS
director
740,000
2.0257%
$6.20$4.59M+56.08%
2023-12-21PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
200,000
0.4555%
$6.17$1.23M+3.57%
2023-12-19PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
277,008
0.6854%
$5.36$1.48M+27.42%
2023-12-18PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
456,923
1.0714%
$5.41$2.47M+18.4%
2023-12-15PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
500,000
1.1857%
$5.97$2.98M+7.92%